Search research articles
Contact Us
Filters
Showing results (541-550 of 558) with videos related to
Page
of 56
Sort By:
Archives of Internal Medicine
|
December 10, 2008
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses
Renata J M Engler, Michael R Nelson, Mary M Klote, et al.
American Journal of Medical Genetics. Part A
|
November 12, 2013
FOXP1 mutations cause intellectual disability and a recognizable phenotype
Anna K Le Fevre, Sharelle Taylor, Neva H Malek, et al.
Applied Optics
|
April 1, 2020
Sapphire advanced mitigation process: wet etch to expose sub-surface damage and increase laser damage resistance and mechanical strength
T Suratwala, R Steele, J Destino, et al.
Analytical Chemistry
|
November 12, 2013
"Retention projection" enables reliable use of shared gas chromatographic retention data across laboratories, instruments, and methods
Brian B Barnes, Michael B Wilson, Peter W Carr, et al.
The Journal of Allergy and Clinical Immunology. Global
|
February 3, 2025
ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trial
Edwin H Kim, Warner W Carr, Amal H Assa'ad, et al.
Optics Express
|
August 10, 2017
Particle damage sources for fused silica optics and their mitigation on high energy laser systems
J Bude, C W Carr, P E Miller, et al.
Molecular Genetics & Genomic Medicine
|
September 5, 2019
The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication
Stephanie Harris, Allison L Cirino, Christina W Carr, et al.
Allergy
|
December 14, 2024
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy
R Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 28, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study
Brian P Vickery, Andrea Vereda, Caroline Nilsson, et al.
The New England Journal of Medicine
|
November 20, 2018
AR101 Oral Immunotherapy for Peanut Allergy
, Brian P Vickery, Andrea Vereda, et al.
Page
of 56
Search research articles
Search
Showing results (541-550 of 558) with videos related to
Sort By:
Page
of 56
Archives of Internal Medicine
|
December 10, 2008
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses
Renata J M Engler, Michael R Nelson, Mary M Klote, et al.
American Journal of Medical Genetics. Part A
|
November 12, 2013
FOXP1 mutations cause intellectual disability and a recognizable phenotype
Anna K Le Fevre, Sharelle Taylor, Neva H Malek, et al.
Applied Optics
|
April 1, 2020
Sapphire advanced mitigation process: wet etch to expose sub-surface damage and increase laser damage resistance and mechanical strength
T Suratwala, R Steele, J Destino, et al.
Analytical Chemistry
|
November 12, 2013
"Retention projection" enables reliable use of shared gas chromatographic retention data across laboratories, instruments, and methods
Brian B Barnes, Michael B Wilson, Peter W Carr, et al.
The Journal of Allergy and Clinical Immunology. Global
|
February 3, 2025
ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trial
Edwin H Kim, Warner W Carr, Amal H Assa'ad, et al.
Optics Express
|
August 10, 2017
Particle damage sources for fused silica optics and their mitigation on high energy laser systems
J Bude, C W Carr, P E Miller, et al.
Molecular Genetics & Genomic Medicine
|
September 5, 2019
The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication
Stephanie Harris, Allison L Cirino, Christina W Carr, et al.
Allergy
|
December 14, 2024
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy
R Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 28, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study
Brian P Vickery, Andrea Vereda, Caroline Nilsson, et al.
The New England Journal of Medicine
|
November 20, 2018
AR101 Oral Immunotherapy for Peanut Allergy
, Brian P Vickery, Andrea Vereda, et al.
Page
of 56